Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8097672rdf:typepubmed:Citationlld:pubmed
pubmed-article:8097672lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:8097672lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8097672lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:8097672lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:8097672lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:8097672lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:8097672pubmed:issue9lld:pubmed
pubmed-article:8097672pubmed:dateCreated1993-6-1lld:pubmed
pubmed-article:8097672pubmed:abstractTextAlteration of chromosome 1 is the most consistent cytogenetic abnormality found in human breast carcinoma. Cytogenetic studies have shown independent alterations on the two arms of chromosome 1, increased copy number of the long arm and loss of the short arm of chromosome 1. These deletions are thought to coincide with the location of tumor suppressor gene(s). We carried out deletion analysis of the 1p region by using restriction fragment length polymorphism markers mapping to the long (six markers) and short arm (22 markers). Thirty-five of the 74 (47.3%) human breast tumors tested showed somatic loss of heterozygosity at one or more loci on the short arm. Two commonly deleted regions, 1p13-p21 and 1p32-pter, were identified. The latter region is frequently involved in other types of tumors, suggesting that it harbors a common tumor suppressor gene. Our findings suggest that two tumor suppressor genes involved in the development of human breast carcinoma may occur on the short arm of the chromosome 1.lld:pubmed
pubmed-article:8097672pubmed:languageenglld:pubmed
pubmed-article:8097672pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8097672pubmed:citationSubsetIMlld:pubmed
pubmed-article:8097672pubmed:statusMEDLINElld:pubmed
pubmed-article:8097672pubmed:monthMaylld:pubmed
pubmed-article:8097672pubmed:issn0008-5472lld:pubmed
pubmed-article:8097672pubmed:authorpubmed-author:CallahanRRlld:pubmed
pubmed-article:8097672pubmed:authorpubmed-author:LidereauRRlld:pubmed
pubmed-article:8097672pubmed:authorpubmed-author:BiècheIIlld:pubmed
pubmed-article:8097672pubmed:authorpubmed-author:ChampèmeM HMHlld:pubmed
pubmed-article:8097672pubmed:authorpubmed-author:MatifasFFlld:pubmed
pubmed-article:8097672pubmed:authorpubmed-author:CroppC SCSlld:pubmed
pubmed-article:8097672pubmed:issnTypePrintlld:pubmed
pubmed-article:8097672pubmed:day1lld:pubmed
pubmed-article:8097672pubmed:volume53lld:pubmed
pubmed-article:8097672pubmed:geneSymbolATP1B1lld:pubmed
pubmed-article:8097672pubmed:geneSymbolNRASlld:pubmed
pubmed-article:8097672pubmed:geneSymbolSPTA1lld:pubmed
pubmed-article:8097672pubmed:geneSymbolMUC1lld:pubmed
pubmed-article:8097672pubmed:geneSymbolMYCL1lld:pubmed
pubmed-article:8097672pubmed:ownerNLMlld:pubmed
pubmed-article:8097672pubmed:authorsCompleteYlld:pubmed
pubmed-article:8097672pubmed:pagination1990-4lld:pubmed
pubmed-article:8097672pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:meshHeadingpubmed-meshheading:8097672-...lld:pubmed
pubmed-article:8097672pubmed:year1993lld:pubmed
pubmed-article:8097672pubmed:articleTitleTwo distinct regions involved in 1p deletion in human primary breast cancer.lld:pubmed
pubmed-article:8097672pubmed:affiliationLaboratory of Oncovirology, Centre René Huguenin, St-Cloud, France.lld:pubmed
pubmed-article:8097672pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8097672pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8097672lld:pubmed